Nuhu Ibrahim Tukur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nuhu Ibrahim Tukur has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Amiru Lawal
1 shared publication- Blessing Mangale1 shared publication
Caroline Nyambura Maina
1 shared publicationDavid Adedokun
1 shared publicationDavid Adeoye Adedokun
1 shared publication- Digby Francis Warner
Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, South Africa
1 shared publication
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Antimicrobial prescribing and stewardship practices among Nigerian veterinarians and para-veterinarians in 2026: a cross-sectional survey
Antimicrobial resistance (AMR) is a global health threat, and veterinary prescribing practices are recognised as contributing to antimicrobial selection pressure in livestock systems. In Nigeria, data on veterinary stewardship practices following the conclusion of the first National Action Plan on AMR (2017–2022) remain limited. This study assessed self-reported antimicrobial prescribing practices, stewardship behaviours, and perceived barriers among veterinary professionals in Nigeria in 2026. A cross-sectional, web-based survey was conducted among veterinarians and para-veterinarians practising in Nigeria using a non-probability convenience and snowball sampling approach. Data were collected on antibiotic prescribing patterns, procurement sources, stewardship practices, and perceptions of AMR drivers, and descriptive statistics were used to summarise responses. A total of 156 respondents were included in the final analysis. Oxytetracycline was the most commonly prescribed antibiotic (88%). Nearly half of respondents (45%) reported occasionally dispensing antibiotics without physical examination, and only 48% reported always advising on withdrawal periods. Post-treatment monitoring was inconsistent, with 25% reporting that they never followed up. Antibiotic procurement occurred primarily through formal channels, chiefly veterinary pharmacies (63%). Waste disposal practices varied, and 57% reported providing no advice or being uncertain about manure management. Lack of diagnostic facilities was the most frequently cited barrier to prudent use (38%). Most respondents (77%) recognised AMR as a serious concern, and 91% supported stricter antibiotic regulations. Despite high awareness of AMR, respondents reported stewardship practices that may contribute to antimicrobial selection pressure, including prescribing without examination, inconsistent withdrawal-period communication, and inadequate waste management. As these findings are based on self-reported practices from a non-probability sample, they should be interpreted as indicative rather than generalisable. Strengthening diagnostic capacity, expanding continuing education, and clarifying national guidelines warrant attention in Nigeria's next AMR policy cycle.
- 21 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAntimicrobial prescribing and stewardship practices among Nigerian veterinarians and para-veterinarians in 2026: a cross-sectional survey
Antimicrobial resistance (AMR) is a global health threat, and veterinary prescribing practices are recognised as contributing to antimicrobial selection pressure in livestock systems. In Nigeria, data on veterinary stewardship practices following the conclusion of the first National Action Plan on AMR (2017–2022) remain limited. This study assessed self-reported antimicrobial prescribing practices, stewardship behaviours, and perceived barriers among veterinary professionals in Nigeria in 2026. A cross-sectional, web-based survey was conducted among veterinarians and para-veterinarians practising in Nigeria using a non-probability convenience and snowball sampling approach. Data were collected on antibiotic prescribing patterns, procurement sources, stewardship practices, and perceptions of AMR drivers, and descriptive statistics were used to summarise responses. A total of 156 respondents were included in the final analysis. Oxytetracycline was the most commonly prescribed antibiotic (88%). Nearly half of respondents (45%) reported occasionally dispensing antibiotics without physical examination, and only 48% reported always advising on withdrawal periods. Post-treatment monitoring was inconsistent, with 25% reporting that they never followed up. Antibiotic procurement occurred primarily through formal channels, chiefly veterinary pharmacies (63%). Waste disposal practices varied, and 57% reported providing no advice or being uncertain about manure management. Lack of diagnostic facilities was the most frequently cited barrier to prudent use (38%). Most respondents (77%) recognised AMR as a serious concern, and 91% supported stricter antibiotic regulations. Despite high awareness of AMR, respondents reported stewardship practices that may contribute to antimicrobial selection pressure, including prescribing without examination, inconsistent withdrawal-period communication, and inadequate waste management. As these findings are based on self-reported practices from a non-probability sample, they should be interpreted as indicative rather than generalisable. Strengthening diagnostic capacity, expanding continuing education, and clarifying national guidelines warrant attention in Nigeria's next AMR policy cycle.
- Open Access
- 11 March 2026
- Published by Elsevier in Preventive Veterinary Medicine: Regional Studies and Reports
- Vol. 1 (1)
Time management practices and service delivery efficiency: An empirical analysis of operational constraints in Nigerian veterinary practices
- 11 March 2026
- Published by Elsevier in Preventive Veterinary Medicine: Regional Studies and Reports
- Vol. 1 (1)
Open AccessTime management practices and service delivery efficiency: An empirical analysis of operational constraints in Nigerian veterinary practices
- Open Access
- 1 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (2) , 141
Discovery of Novel Derivatives of Catechin Gallate with Antimycobacterial Activity from Kirkia wilmsii Engl. Extracts
Background/Objectives: The increase in incidences of multidrug resistance exacerbates tuberculosis-related global health challenges and underscores a call for more efforts for development of new antitubercular drugs, including the use of medicinal plants, especially those that have been used for generations by traditional healers. Despite reports of antimicrobial activity and chemical profiling of Kirkia wilmsii (K. wilmsii) extracts, chemical structures of the bioactive agents have not been elucidated. Here, we used a combination of bioactivity-guided fractionation, mass spectrometry, and nuclear magnetic resonance to purify and elucidate the chemical structure of antimycobacterial agents contained in leaf and twig extracts for K. wilmsii. Results: After overnight extraction with acetone and 90 g of dry twigs and leaves produced 5.38 g (6%) and 4.56 g (5%) of product, which displayed moderate antimycobacterial activity of 0.5 and 1 mg/mL, respectively. The antimycobacterial activity was increased six- and three-fold, respectively, after the crude extracts were subjected to solvent–solvent partitioning. Due to many bioactive fractions being obtained after silica gel chromatography purification, fraction 5 of twig extract was prioritized for further purification due to its low minimum inhibitory concentration (MIC) (0.25 mg/mL) and cytotoxicity (20%, in THP-1 cells). Sequential purification of the fraction 5 (twig extract) extracts through the C18 cartridge and high-performance liquid chromatography (HPLC) produced four fractions, which were subjected to structural elucidation. The high-resolution mass spectrometric analyses revealed that the first two eluting peaks had the same mass ion of 441.0822 m/z (M − H−), which corresponded to catechin monogallate, and so were the last two eluting peaks, which had a mass ion of 539.0932 m/z (M − H−), corresponding to catechin digallate. Further analyses by 1H, 13C, and 2D NMR confirmed the chemical structures of compounds eluting in the first two peaks on HPLC as structural isomers of catechin 3′-monogallate and catechin 4′-monogallate (MIC not determined). Similarly, compounds eluting in the last two peaks were identified as structural isomers catechin 3′-digallate and catechin 4′-digallate, with an MIC of 250 µg/mL against Mycobacterium smegmatis and Mycobacterium tuberculosis H37Rv and an MBC of 500 μg/mL against M. smegmatis. Conclusions: To the best of our knowledge, this study is the first to report the structure of catechin 3′- and 4′-digallate, their antimycobacterial activity, and the existence of acyl migration involving galloyl 3′ and 4′-hydroxyl groups of catechin ring B.
- 1 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (2) , 141
Open AccessDiscovery of Novel Derivatives of Catechin Gallate with Antimycobacterial Activity from Kirkia wilmsii Engl. Extracts
Background/Objectives: The increase in incidences of multidrug resistance exacerbates tuberculosis-related global health challenges and underscores a call for more efforts for development of new antitubercular drugs, including the use of medicinal plants, especially those that have been used for generations by traditional healers. Despite reports of antimicrobial activity and chemical profiling of Kirkia wilmsii (K. wilmsii) extracts, chemical structures of the bioactive agents have not been elucidated. Here, we used a combination of bioactivity-guided fractionation, mass spectrometry, and nuclear magnetic resonance to purify and elucidate the chemical structure of antimycobacterial agents contained in leaf and twig extracts for K. wilmsii. Results: After overnight extraction with acetone and 90 g of dry twigs and leaves produced 5.38 g (6%) and 4.56 g (5%) of product, which displayed moderate antimycobacterial activity of 0.5 and 1 mg/mL, respectively. The antimycobacterial activity was increased six- and three-fold, respectively, after the crude extracts were subjected to solvent–solvent partitioning. Due to many bioactive fractions being obtained after silica gel chromatography purification, fraction 5 of twig extract was prioritized for further purification due to its low minimum inhibitory concentration (MIC) (0.25 mg/mL) and cytotoxicity (20%, in THP-1 cells). Sequential purification of the fraction 5 (twig extract) extracts through the C18 cartridge and high-performance liquid chromatography (HPLC) produced four fractions, which were subjected to structural elucidation. The high-resolution mass spectrometric analyses revealed that the first two eluting peaks had the same mass ion of 441.0822 m/z (M − H−), which corresponded to catechin monogallate, and so were the last two eluting peaks, which had a mass ion of 539.0932 m/z (M − H−), corresponding to catechin digallate. Further analyses by 1H, 13C, and 2D NMR confirmed the chemical structures of compounds eluting in the first two peaks on HPLC as structural isomers of catechin 3′-monogallate and catechin 4′-monogallate (MIC not determined). Similarly, compounds eluting in the last two peaks were identified as structural isomers catechin 3′-digallate and catechin 4′-digallate, with an MIC of 250 µg/mL against Mycobacterium smegmatis and Mycobacterium tuberculosis H37Rv and an MBC of 500 μg/mL against M. smegmatis. Conclusions: To the best of our knowledge, this study is the first to report the structure of catechin 3′- and 4′-digallate, their antimycobacterial activity, and the existence of acyl migration involving galloyl 3′ and 4′-hydroxyl groups of catechin ring B.
- Open Access
Identification of mycobacterial efflux pump inhibiting compounds from Berberis holstii Engl. and determination of their mechanism of action
Mycobacterium tuberculosis (Mtb), the causative agent for tuberculosis (TB), is the leading infectious killer of humankind. In 2023, an estimated 10.8 million new cases of TB and 1.25 million deaths were reported globally. Sub-Saharan Africa faces a heavy TB burden, worsened by high HIV-AIDS prevalence and rising drug resistance, making novel anti-TB therapies a pressing priority. This study investigated the efflux inhibition (EI) activity of compounds characterised from Berberisholstii Engl. extracts. Following in vitro evaluation of the antimycobacterial activity of aqueous and organic extracts against the non-pathogenic mycobacterial model, Mycobacterium smegmatis (Msm), and Mtb. Thereafter, molecular docking of several compounds identified in chromatographic fractions onto Rv1258c, MmpS5-MmpL5 and Rv2333c Mtb efflux pumps (EPs) was undertaken to infer their binding modes and affinities. Subsequently, fractions containing potentially active compounds were tested in combination with spectinomycin (SPEC) and fractional inhibitory concentration index (FICI) values determined. Validation of Mtb efflux pump inhibition was performed using CRISPRi knockdown strains of Rv1258c and Rv2333c. MeOH extracts of the root and the stem bark, and aqueous extracts of the roots, exhibited minimum inhibitory concentration (MIC99) values of 906.25μg/ml, 4500 μg/ml and 1875 μg/ml, respectively, against wild-type Msm. On the other hand, MeOH extract of the leaves and aqueous extract of the stem bark had MIC99 values of 60.43 μg/ml and 1.74 μg/ml respectively, against wild-type Mtb. Molecular docking of chillanamine, isoboldine, berberrubine, reticuline, N-methylcoclaurine, thalifoline, apoglaziovine, and orientine onto Mtb Rv1258c, MmpS5-MmpL5 and Rv2333c revealed string binding affinities of <-5 kcal/mol. Of the seven fractions containing the bioactive compounds evaluated in checkerboard assays, six were synergistic with SPEC (FICI <0.5), with two fractions lowering the MIC99 of SPEC by 8-fold against wild-type Mtb. This study identified phytochemicals with probable Mtb efflux pump inhibition, warranting further investigation for potential use in TB combination therapy.
Open AccessIdentification of mycobacterial efflux pump inhibiting compounds from Berberis holstii Engl. and determination of their mechanism of action
Mycobacterium tuberculosis (Mtb), the causative agent for tuberculosis (TB), is the leading infectious killer of humankind. In 2023, an estimated 10.8 million new cases of TB and 1.25 million deaths were reported globally. Sub-Saharan Africa faces a heavy TB burden, worsened by high HIV-AIDS prevalence and rising drug resistance, making novel anti-TB therapies a pressing priority. This study investigated the efflux inhibition (EI) activity of compounds characterised from Berberisholstii Engl. extracts. Following in vitro evaluation of the antimycobacterial activity of aqueous and organic extracts against the non-pathogenic mycobacterial model, Mycobacterium smegmatis (Msm), and Mtb. Thereafter, molecular docking of several compounds identified in chromatographic fractions onto Rv1258c, MmpS5-MmpL5 and Rv2333c Mtb efflux pumps (EPs) was undertaken to infer their binding modes and affinities. Subsequently, fractions containing potentially active compounds were tested in combination with spectinomycin (SPEC) and fractional inhibitory concentration index (FICI) values determined. Validation of Mtb efflux pump inhibition was performed using CRISPRi knockdown strains of Rv1258c and Rv2333c. MeOH extracts of the root and the stem bark, and aqueous extracts of the roots, exhibited minimum inhibitory concentration (MIC99) values of 906.25μg/ml, 4500 μg/ml and 1875 μg/ml, respectively, against wild-type Msm. On the other hand, MeOH extract of the leaves and aqueous extract of the stem bark had MIC99 values of 60.43 μg/ml and 1.74 μg/ml respectively, against wild-type Mtb. Molecular docking of chillanamine, isoboldine, berberrubine, reticuline, N-methylcoclaurine, thalifoline, apoglaziovine, and orientine onto Mtb Rv1258c, MmpS5-MmpL5 and Rv2333c revealed string binding affinities of <-5 kcal/mol. Of the seven fractions containing the bioactive compounds evaluated in checkerboard assays, six were synergistic with SPEC (FICI <0.5), with two fractions lowering the MIC99 of SPEC by 8-fold against wild-type Mtb. This study identified phytochemicals with probable Mtb efflux pump inhibition, warranting further investigation for potential use in TB combination therapy.